Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye

NCT01348672 is registered in ClinicalTrials.gov with University of Toronto as lead sponsor.

NCT NCT01348672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01348672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye
Lead sponsor
University of Toronto
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2012
Completion date
August 31, 2015
Enrollment
381 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration, diabetic retinopathy., glaucoma